The test developer will use the Series B funding to complete a 10,000-subject clinical trial ahead of a planned launch in 2025.Dive Brief:Harbinger Health has raised $140 million to clinically validate a blood-based cancer screening test ahead of a planned launch in 2025. The test is designed to identify epigenetic changes that signal the start […]
